Decision of the EEA Joint Committee No 297/2019 of 13 December 2019 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2020/315]
Date: 2019-12-13
Institutions: EEA Joint Committee
Subjects: EU Member State, European Economic Area, chemical product, health risk, market approval, plant health control, plant health product, revision of an agreement




L_2020068EN.01003501.xml










5.3.2020   


EN


Official Journal of the European Union


L 68/35








            DECISION OF THE EEA JOINT COMMITTEE
         
No 297/2019
of 13 December 2019
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2020/315]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2019/324 of 25 February 2019 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances bifenthrin, carboxin, FEN 560 (also called fenugreek or fenugreek seed powder), pepper dust extraction residue and sodium aluminium silicate (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 amending Regulation (EU) No 1141/2010 and Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of 1-methylcyclopropene, famoxadone, mancozeb, methiocarb, methoxyfenozide, pirimicarb, pirimiphos-methyl and thiacloprid (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) 2019/337 of 27 February 2019 approving the active substance mefentrifluconazole in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (4) is to be incorporated into the EEA Agreement.












(5)


Commission Implementing Regulation (EU) 2019/344 of 28 February 2019 concerning the non-renewal of approval of the active substance ethoprophos, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (5) is to be incorporated into the EEA Agreement.












(6)


Commission Implementing Regulation (EU) 2019/481 of 22 March 2019 approving the active substance flutianil, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (6) is to be incorporated into the EEA Agreement.












(7)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:






(1)


the following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






‘—



32019 R 0291: Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 (OJ L 48, 20.2.2019, p. 17),










—



32019 R 0324: Commission Implementing Regulation (EU) 2019/324 of 25 February 2019 (OJ L 57, 26.2.2019, p. 1),










—



32019 R 0337: Commission Implementing Regulation (EU) 2019/337 of 27 February 2019 (OJ L 60, 28.2.2019, p. 12),










—



32019 R 0344: Commission Implementing Regulation (EU) 2019/344 of 28 February 2019 (OJ L 62, 1.3.2019, p. 7),










—



32019 R 0481: Commission Implementing Regulation (EU) 2019/481 of 22 March 2019 (OJ L 82, 25.3.2019, p. 19).’;














(2)


the following indent is added in point 13zzze (Commission Implementing Regulation (EU) No 686/2012):






‘—



32019 R 0336: Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 (OJ L 60, 28.2.2019, p. 8).’;














(3)


the following points are inserted after point 13zzzzzzzzzt (Commission Implementing Regulation (EU) 2019/158):






‘13zzzzzzzzzu.



32019 R 0337: Commission Implementing Regulation (EU) 2019/337 of 27 February 2019 approving the active substance mefentrifluconazole in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 60, 28.2.2019, p. 12).










13zzzzzzzzzv.



32019 R 0344: Commission Implementing Regulation (EU) 2019/344 of 28 February 2019 concerning the non-renewal of approval of the active substance ethoprophos, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 62, 1.3.2019, p. 7).










13zzzzzzzzzw.



32019 R 0481: Commission Implementing Regulation (EU) 2019/481 of 22 March 2019 approving the active substance flutianil, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 82, 25.3.2019, p. 19).’










Article 2
The texts of Implementing Regulations (EU) 2019/291, (EU) 2019/324, (EU) 2019/336, (EU) 2019/337, (EU) 2019/344 and (EU) 2019/481 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 14 December 2019, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 13 December 2019.


For the EEA Joint Committee


The President

Gunnar PÁLSSON
            





(1)  
            OJ L 48, 20.2.2019, p. 17.

(2)  
            OJ L 57, 26.2.2019, p. 1.

(3)  
            OJ L 60, 28.2.2019, p. 8.

(4)  
            OJ L 60, 28.2.2019, p. 12.

(5)  
            OJ L 62, 1.3.2019, p. 7.

(6)  
            OJ L 82, 25.3.2019, p. 19.

(*1)  No constitutional requirements indicated.